CAPTRUST Financial Advisors’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-9,852
Closed -$125K 3698
2022
Q2
$125K Sell
9,852
-1,156
-11% -$14.8K ﹤0.01% 2040
2022
Q1
$142K Buy
11,008
+2,886
+36% +$38.1K ﹤0.01% 1990
2021
Q4
$129K Buy
8,122
+191
+2% +$3.26K ﹤0.01% 1957
2021
Q3
$155K Sell
7,931
-94
-1% -$1.87K ﹤0.01% 1737
2021
Q2
$183K Sell
8,025
-1,541
-16% -$32K ﹤0.01% 1592
2021
Q1
$176K Buy
9,566
+9,176
+2,353% +$150K ﹤0.01% 1558
2020
Q4
$6K Buy
390
+167
+75% +$2.18K ﹤0.01% 2790
2020
Q3
$3K Buy
+223
New +$2.2K ﹤0.01% 2684

Other funds holding SEM

CAPTRUST Financial Advisors's SEM Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Select Medical (SEM) in Q3 2022, closing a stake of 9,852 shares — an estimated $125K sold.

CAPTRUST Financial Advisors first reported a position in SEM in Q3 2020 and held it in 8 quarters. The position peaked at $183K in Q2 2021. 216 funds tracked by Wall St. Rank hold SEM as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Select Medical position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 9,852 Select Medical shares in Q3 2022, an estimated $125K.
  • CAPTRUST Financial Advisors first reported a position in Select Medical in Q3 2020 and held it in 8 quarters.
  • CAPTRUST Financial Advisors's Select Medical position peaked at $183K in Q2 2021.
  • 216 funds tracked by Wall St. Rank held Select Medical as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.